Virtual Hypertension Management Pilot

Not Applicable

Completed

• Conditions: Digital Health; Electronic Health Record; Hypertension
• Interventions: Other: Usual care; Other: Connected-device

• Registration Number: NCT03291535
• Lead Sponsor: Stanford University

Brief Summary

Investigators are examining the quality improvement impact of providing patients with a an electronic health record-connected blood pressure cuff. Investigators will give half of patients already eligible for hypertension management within a clinical pharmacist panel, the ability to upload their blood pressure data into Stanford's electronic health record.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-07-26
• Study First Submitted: 2017-08-17
• Study First Submitted QC: 2017-09-21
• Study First Posted: 2017-09-25
• Primary Completion: 2022-03-01
• Study Completion: 2022-03-01
• Status Verified: 2022-08
• Last Update Submitted: 2022-08-18
• Last Update Posted: 2022-08-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

• Hypertension as defined by clinical pharmacist usual care panel (2 or more readings of blood pressure >140/90)

Read More

Exclusion Criteria

• Pregnancy
• Chronic kidney disease III or IV
• Systolic heart failure with ejection fraction <35%
• Current use of 3 or more anti-hypertension drugs

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Control	Usual care	This arm will consist of the usual care of management of hypertension by a clinical pharmacist.
Intervention	Connected-device	This arm will consistent of usual care plus the addition of a blood pressure cuff that will allow patients to upload data to the electronic health record via a secure portal.

Primary Outcome Measures

Name	Time	Method
Change in blood pressure over time in control group vs. the intervention group	From enrollment to 6 months later	Difference in the change in blood pressure between the control group and intervention group.

Secondary Outcome Measures

Name	Time	Method
Blood pressure control	From enrollment to 6 months later	Time to reach target blood pressure control (Adults 18-59 years of age \<140/90 mm Hg, Adults 60-85 years of age, without a diagnosis of diabetes, \<150/90 mm Hg, Adults 60-85 years of age, with a diagnosis of diabetes, \<140/90 mm Hg)
Patient remote interactions	From enrollment to 6 months later	Measurement of the number of patient phone calls plus patient-portal messages to the clinical pharmacist
Medication changes	From enrollment to 6 months later	Number of changes in medication or medication dose
Patient visits	From enrollment to 6 months later	Measurement of the number of in-person visits

Trial Locations

Locations (2)

Stanford Primary Care; 🇺🇸 Portola Valley, California, United States

Stanford Primary Care Clinic; 🇺🇸 Santa Clara, California, United States